Sector: Pharmaceuticals & Biotechnology

Small Cap

Kopran Share Price

Kopran Ltd.

₹193.13

-0.78(-0.40%)

Trade Now

27th May 2026 | 3:28 PM

NSE : KOPRAN

Open Free Demat Account

Kopran Performance

Price Movement

₹193.13

₹191.50

₹202.80

↘ Today's Low↗ Today's High

1 Year Performance

₹193.13

₹107.00

₹212.58

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹202.80

Low₹191.50

Open at₹192.81

Prev Close₹193.91

Volumes14.25 L

Avg Price₹197.74

Lower Circuit₹155.13

Upper Circuit₹232.69

Historical Performance

3M High₹203.50

3M Low₹107.00

1 Yr High₹212.58

1 Yr Low₹107.00

3 Yr High₹369.70

3 Yr Low₹107.00

5 Yr High₹370.45

5 Yr Low₹96.00

Kopran Fundamentals

Market Cap

Above industry Median

934.70 Cr.

PE Ratio (TTM)

Above industry Median

36.30

Dividend Yield

High in industry

1.50

Net Profit TTM

33% decr over last year

25.73

Net Profit Growth

33% decr over last year

25.73

PEG Ratio

Negative PEG TTM

-1.10

ROE

35% decr over last year

4.85

Operating Revenue TTM

683.82

Operating Revenue Growth

8.1% incr over last year

Book Value

Below industry Median

1.80

MFI

MFI strongly Overbought

RSI

RSI Overbought

72.63

EPS (TTM)

5.33

Debt to Equity

0.29

Face Value

Operating Profit Margin Qtr.

9.09

Operating Profit Qtr.

32.95

Net Profit Qtr.

18.87

Operating Revenue Qtr.

234.02

PB Ratio

1.80

Kopran Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	118.04	93.88	42.39	52.78	77.01
Operating Expense	91.45	76.20	45.60	46.26	63.65
Operating Profit	26.59	17.68	-3.21	6.52	13.36
Depreciation	1.34	1.25	1.16	1.22	1.24
Interest	1.17	1.16	0.83	1.04	1.26
Tax	6.33	3.45	-0.88	1.09	3.11
Net Profit	18.74	12.13	-3.99	3.52	8.60

Kopran Technicals

Kopran Ltd. EMA & SMA

₹193.13

-0.78 (-0.40%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹179.8

Day EMA10 ₹172.6

Day EMA12 ₹170.9

Day EMA20 ₹165.7

Day EMA26 ₹162.5

Day EMA50 ₹153.8

Day EMA100 ₹148.6

Day EMA200 ₹154.4

Kopran Support and Resistance

Resistance

First Resistance₹201.87

Second Resistance₹209.84

Third Resistance₹216.17

Support

First Support₹187.57

Second Support₹181.24

Third Support₹173.27

Technical Indicators

Day RSI72.63

Day MFI92.00

Day ADX34.30

Day Commodity Channel Index300.50

William-17.17

Day MACD8.33

Day MACD Signal Line6.16

Day ATR10.53

Day ROC12544.71

Day ROC2124.82

Kopran Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	44.5	44.4	44.4	44.4	44.4	44.4
FII	0.9	1.1	0.8	0.6	0.4	0.6
DII	0	0	0	0	0	0
Public	54.7	54.4	54.8	55	55.2	55

Kopran Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	10.66 L	44.43 L	24.00%
Week	9.47 L	39.69 L	23.86%
1 Month	3.62 L	14.17 L	25.55%
6 Month	1.71 L	6.09 L	28.02%

Kopran SWOT Analysis

Strengths23

Weakness9

Opportunity1

Threats0

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Kopran Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
04 Sep, 2025	3	FINAL	04 Sep, 2025	Equity Share
02 Sep, 2024	3	FINAL		Equity Share
07 Sep, 2023	3	FINAL		Equity Share
04 Aug, 2022	3	FINAL		Equity Share
05 Aug, 2021	1.5	FINAL		Equity Share
05 Nov, 2020	1.5	INTERIM	07 Nov, 2020	Equity Share

Kopran Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Innova Captab Ltd.
Price (₹)	₹486.75	₹6.46	₹132.26	₹14.29	₹563.80	₹844
% Change	0.64%	0.00%	-0.74%	1.71%	1.08%	0.06%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	-	₹502.55	₹1,630.02
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	-	₹57.92	₹140.92
PE TTM	-	-1.50	34.40	-	28.00	34.40
1 Year Return	23.66	545	4.6	56.59	-22.32	-2.92
ROCE	3.56	-5.63	-	-	23.87	15.27

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 80.00

+1.60%

SIGACHI

Sigachi Industries Ltd.

₹ 20.57

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 821.00

-0.22%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 544.00

-2.60%

ZIMLAB

Zim Laboratories Ltd.

₹ 102.60

-0.77%

MEDICO

Medico Remedies Ltd.

₹ 49.00

+1.51%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 197.52

-1.50%

LASA

Lasa Supergenerics Ltd.

₹ 8.63

+4.99%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 372.20

-1.22%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 311.50

+2.05%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.31

+4.95%

BROOKS

Brooks Laboratories Ltd.

₹ 62.19

+5.00%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2239.00

+1.14%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 129.90

-0.20%

ALPA

Alpa Laboratories Ltd.

₹ 71.15

+0.66%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 378.90

+0.70%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.41

+1.14%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.70

-0.66%

INDOCO

Indoco Remedies Ltd.

₹ 203.00

+5.11%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 134.90

-0.93%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 760.00

+1.68%

PANACEABIO

Panacea Biotec Ltd.

₹ 413.50

-2.49%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 284.95

+4.65%

FAQ's on KOPRAN

What is the current share price of Kopran Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Kopran Ltd. is ₹ 193.13 on the NSE and ₹ 193.05 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Kopran Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Kopran Ltd. is approximately ₹ 934.7 Cr.

What are the PE and PB ratios for Kopran Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Kopran Ltd. is 36.3, and the Price-to-Book (PB) ratio is 1.8.

What is the 52-Week High and Low for Kopran Ltd.?

Over the past 52 weeks, the highest price reached by Kopran Ltd. shares was ₹ 212.58, and the lowest price was ₹ 107.

What is the current dividend yield for Kopran Ltd.?

As of 6 June 2025, the dividend yield for Kopran Ltd. is 1.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Kopran Ltd.?

Significant shareholdings in Kopran Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Kopran Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Kopran Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Kopran Ltd.?

Kopran Ltd. last declared a FINAL dividend of ₹ 3 per share for the financial period ending 2025. The record date was set as 2025-09-04, and the payment was/is scheduled around 2025-09-04. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy